Physician profile
Annika W Ehrlich
NPI 1568868479
$128,487.36
in general payments reported to CMS, 2019-2025
12 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19K · 2022: $15K · 2023: $12K · 2024: $35K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $46K · Consulting Fee: $27K · Travel and Lodging: $11K · Food and Beverage: $5,338 · Honoraria: $5,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45,811.25 |
| Consulting Fee | $27,072.22 |
| Travel and Lodging | $10,624.61 |
| Food and Beverage | $5,338.04 |
| Honoraria | $5,263.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $101,920.33 | 2021-2025 | |
| Lilly USA, LLC | $11,210.09 | 2021-2024 | Emgality |
| Pfizer INC. | $5,320.84 | 2024-2025 | |
| Axsome Therapeutics, INC. | $4,412.38 | 2025 | |
| Lundbeck LLC | $2,649.98 | 2024-2025 | Vyepti |
| Allergan, INC. | $1,587.50 | 2021 | |
| Biodelivery Sciences International, INC. | $750.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $365.63 | 2024 | Relistor |
| Biogen, INC. | $125.00 | 2025 | Spinraza |
| Scynexis, INC. | $88.48 | 2022 | |
| Neurocrine Biosciences, INC. | $40.51 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $16.62 | 2024 | Ajovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annika Ehrlich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.